Back to Search
Start Over
Renal Impairment, Cardiovascular Disease, and the Short-Term Efficacy and Safety of PCSK9 Targeted by Inclisiran.
- Source :
-
Mayo Clinic proceedings [Mayo Clin Proc] 2020 Jan; Vol. 95 (1), pp. 12-14. - Publication Year :
- 2020
- Subjects :
- Humans
RNA, Small Interfering
Cardiovascular Diseases
Proprotein Convertase 9
Subjects
Details
- Language :
- English
- ISSN :
- 1942-5546
- Volume :
- 95
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Mayo Clinic proceedings
- Publication Type :
- Editorial & Opinion
- Accession number :
- 31902406
- Full Text :
- https://doi.org/10.1016/j.mayocp.2019.11.010